Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-12 Purchase |
2022-01-14 2:13 pm |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
15,000 | $12.6 | $189,000 | 258,885 (Direct) |
View |
| 2021-02-12 Purchase |
2021-02-16 6:03 pm |
Tishman Speyer Innovation Corp. II | TSIB | Kazam Joshua A Director |
25,000 | $0 | $0 | 30,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-25 Option Award |
2024-06-26 4:32 pm |
N/A 2034-06-24 |
Kronos Bio Inc. | KRON | Kazam Joshua A Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:28 pm |
N/A 2034-06-05 |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
191,082 | $0 | 191,082 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 4:09 pm |
N/A 2033-06-21 |
Kronos Bio Inc. | KRON | Kazam Joshua A Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:56 pm |
N/A 2033-06-13 |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
116,120 | $0 | 116,120 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-29 4:08 pm |
N/A 2032-06-21 |
Kronos Bio Inc. | KRON | Kazam Joshua A Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:58 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
44,178 | $0 | 303,063 (Direct) |
View |
| 2022-03-07 Gift |
2022-03-09 6:26 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
412,618 | $0 | 671,503 (Direct) |
View |
| 2022-03-07 Other |
2022-03-09 6:26 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
412,618 | $0 | 671,503 (Direct) |
View |
| 2022-03-07 Gift |
2022-03-09 4:40 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Kazam Joshua A Director |
211,000 | $0 | 94,481 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:16 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | Kazam Joshua A Director |
20,600 | $0 | 20,600 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-11 5:43 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
16,498 | $0 | 243,885 (Direct) |
View |
| 2021-06-11 Gift |
2021-06-11 5:43 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
500,000 | $0 | 243,885 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-07 6:39 pm |
N/A N/A |
TS Innovation Acquisitions Corp. | LTCH | Kazam Joshua A Former Director Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-02-11 8:27 pm |
N/A N/A |
Tishman Speyer Innovation Corp. II | TSIB | Kazam Joshua A Director |
0 | $0 | 30,000 (Direct) |
View |
| 2020-10-21 Ownership |
2021-02-03 4:22 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
305,918 | $0 | 727,387 (Direct) |
View |
Ownership |
2020-11-09 6:44 pm |
N/A N/A |
TS Innovation Acquisitions Corp. | TSIA | Kazam Joshua A Director |
0 | $0 | 30,000 (Direct) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:47 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Kazam Joshua A Director |
179,927 | $0 | 94,481 (Direct) |
View |
Ownership |
2020-10-08 7:09 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Kazam Joshua A Director |
0 | $0 | 94,481 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 4:04 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
9,969 | $0 | 1,033,305 (Direct) |
View |
| 2020-04-24 Other |
2020-04-28 4:33 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director |
8,039 | $0 | 1,031,375 (Direct) |
View |